Home > Protocol Summaries: Compounds > amoxicillin/clavulanic acid

Protocol Summaries: amoxicillin/clavulanic acid

Protocol Summaries for amoxicillin/clavulanic acid
GSK
Study ID		 Phase Title Status
103997 Phase 4 An open, non-comparative study to evaluate the efficacy and safety of AUGMENTIN 1gm (875mg Amoxicillin/125mg Clavulanic acid) po q 12 hours in the treatment of uncomplicated skin and soft tissue infections in Pakistan Completed
AUG102821 Phase 1 An open-label study to determine the pharmacokinetic profiles of amoxicillin and clavulanate in adolescent patients weighing at least 40 kg and no more than 16 years of age receiving Augmentin XR (amoxicillin 2000 mg/clavulanate 125 mg) orally twice daily for 10 days. Completed

Filter list by: